AstraZeneca completes acquisition of Pearl Therapeutics
AstraZeneca completed the purchase of California-based Pearl Therapeutics for up to $1.15 billion as part of its strategy to strengthen its portfolio in the respiratory disease treatment arena, the...
View ArticleAstraZeneca and HealthCore recognized among top influencers in the industry
Executives from AstraZeneca and its partner HealthCore, have topped a list of top influencers by HealthNetwork Communications, the global biopharmaceutical announced. HealthNetwork Communications has...
View ArticleAstraZeneca aided by Michael J. Fox Foundation
The Michael J. Fox Foundation for Parkinson's Research has awarded a $465,000 grant to AstraZeneca to research levodopa-induced dyskinesias (LID), a side effect from commonly used Parkinson's disease...
View ArticleAstraZeneca accredited for commitment to help workers prevent and combat cancer
AstraZeneca has been awarded the CEO Cancer Gold Standard accreditation for the eighth consecutive year in recognitition for its commitment to help employees and their familes in cancer prevention,...
View ArticleAnnual gala for bio-brains
DelawareBio's 2013 Annual Awards Gala, recognizing the best of the best in advancing the First State's biotechnology industry through innovation, is on tap for May. The reception will take place from...
View ArticleAgilent Technologies bringing bio-types together
Wilmington-based Agilent Technologies will set the stage for a meetup of bioscience leaders at a coming event sponsored by DelawareBio. The meetup will take place from 7:30 a.m. to 9 a.m. on May 1, at...
View ArticleAstraZeneca employees fill backpacks for local students
AstraZeneca employees donated personal funds and resources and filled 75 backpacks for students at Las Americas ASPIRA Academy. The backpacks for students from the Wilmington-based bilingual charter...
View ArticleAstraZeneca among Top 100 Best Companies for working moms
AstraZeneca was ranked 12th in a top 100 list of best companies for working moms. The designation for the biopharmaceutical firm, which has its offices for the Americas in Fairfax, was made by Working...
View ArticleAstraZeneca advances potential treatment for asthma
AstraZeneca announced progress of a potential asthma treatment developed by the pharma's biologics arm, Maryland-based MedImmune. "We are pleased to begin the Phase III trial program for benralizumab...
View ArticleAstraZeneca awarded damages in patent infringement case
The U.S. District Court for the Southern District of New York has ordered Apotex Corp., Apotex Inc., and Torpharm Inc., to pay approximately $76 million in damages to AstraZeneca. "This ruling is a...
View Article
